Following child deaths in Madhya Pradesh and Rajasthan allegedly linked to contaminated Coldrif cough syrup, CDSCO has launched inspections across six States. Tamil Nadu and Madhya Pradesh have banned the syrup, while authorities investigate manufacturing lapses and advise caution for paediatric use

New Delhi: Central drug regulator CDSCO has initiated risk-based inspection of drug manufacturing units in six States following collection of 19 samples including that of cough syrups, antipyretics and antibiotics in the wake of child deaths in Madhya Pradesh and Rajasthan allegedly due to contaminated cough syrups.

The manufacturing units are in Himachal Pradesh, Uttarakhand, Gujarat, Tamil Nadu, Madhya Pradesh and Maharashtra where 19 samples of different drugs were manufactured, source

See Full Page